Development and clinical application of a stability-indicating chromatography technique for the quantification of diazoxide

Diazoxide is a potential candidate for the treatment of transitional hypoglycaemia in infants. A clinical trial is currently underway to investigate whether low-dose oral diazoxide is beneficial for severe or recurrent transitional neonatal hypoglycaemia (the NeoGluCO Study, registration ANZCTR12620...

Descripción completa

Detalles Bibliográficos
Autores principales: Purohit, Trusha J., Laing, Don, McKinlay, Christopher JD., Alsweiler, Jane M., Hanning, Sara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559840/
https://www.ncbi.nlm.nih.gov/pubmed/37810084
http://dx.doi.org/10.1016/j.heliyon.2023.e20101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559840/
https://www.ncbi.nlm.nih.gov/pubmed/37810084
http://dx.doi.org/10.1016/j.heliyon.2023.e20101

Ejemplares similares